Red light therapy for slowing vision loss in severe nearsightedness
Part of Eyes & vision clinical trials.
This trial tests if daily low-level red light can protect the back of the eye in people with severe nearsightedness. It aims to slow damage that leads to vision loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 55 years old.
- You have severe nearsightedness (at least -6.00 diopters and long eyeball length).
- Your vision is not worse than 20/200 (can read large letters on an eye chart).
- You have specific types of scarring or thinning at the back of the eye, or your vision is between 20/50 and 20/200.
- You do not have other eye diseases like active bleeding, diabetes in the eye, or glaucoma.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special red light therapy can help slow down the progression of nearsightedness in children. It compares different amounts of light and how often it is used to find the best way to keep myopia from getting worse.
This study tests if red light therapy can cause short-term changes in the back of the eye (the choroid and retina) in people with mild to moderate nearsightedness (myopia). It may help researchers understand if this therapy could be used to slow down or improve nearsightedness.
This study tests whether repeated low-level red-light therapy can slow how fast nearsightedness (myopia) gets worse in children. It may help protect future eyesight, but your child must meet specific vision and health requirements and follow the study plan.
This study tests whether a special red-light device can safely slow or stop nearsightedness from getting worse in adults. You'll use the light at home for a few minutes each day, and the team will check your vision over time.
This study tests if a special red light device can help adults with very high nearsightedness. You would use the device at home as part of the trial, and researchers will check if it slows vision changes.
This study tests how well a special imaging device (AO-SLO) can measure cells in the back of the eye, and how these cells change in people who use repeated low-level red-light therapy for myopia (nearsightedness). It may help researchers understand if this therapy is safe and effective for controlling myopia.
Hear when a new Pathologic Myopia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.